Did you know?
Multiple sclerosis is the most common degenerative neurological condition diagnosed in young adults, with over 75% of people diagnosed under the age of 40.
New MS research projects announced
There is good news in the MS research world, as the National Health and Medical Research Council (NHMRC) has announced new research projects that will receive funding from 2015. Of these research projects, four new MS research projects will benefit from this funding over the next three to five years.Read more
Onwards and upwards – MS Members move to bigger premises
Members of the Multiple Sclerosis Society of WA (MSWA) bade farewell to Seabrooke House in Rockingham after almost 19 years and moved into a newer and larger premises on Council Avenue last Friday.Read more
LED upgrade lighting for Wilson facility
The MS Society of WA has received funding by the Australian Government to carry out an upgrade of its lighting systems.Read more
Lemtrada (Alemtuzumab) recommended for the Pharmaceutical Benefits Scheme
Alemtuzumab, to be marketed as Lemtrada, is the latest drug treatment for people with relapsing remitting MS.Read more
Where does the money go?
Without your contribution, we couldn't continue to provide services to thousands of Western Australians with MS.